Reversible and non-competitive antagonist profile of CPCCOEt at the human type 1α metabotropic glutamate receptor
- 1 December 1998
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 37 (12), 1645-1647
- https://doi.org/10.1016/s0028-3908(98)00132-4
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Expression and Purification of the Extracellular Ligand Binding Region of Metabotropic Glutamate Receptor Subtype 1Journal of Biological Chemistry, 1998
- Effects of Human Type 1α Metabotropic Glutamate Receptor Expression Level on Phosphoinositide and Ca2+ Signalling in an Inducible Cell Expression SystemJournal of Neurochemistry, 1998
- Enhanced Type 1α Metabotropic Glutamate Receptor-Stimulated Phosphoinositide Signaling after Pertussis Toxin TreatmentMolecular Pharmacology, 1997
- PHARMACOLOGY AND FUNCTIONS OF METABOTROPIC GLUTAMATE RECEPTORSAnnual Review of Pharmacology and Toxicology, 1997
- (RS)-2-Chloro-5-Hydroxyphenylglycine (CHPG) Activates mGlu5, but not mGlu1, Receptors Expressed in CHO Cells and Potentiates NMDA Responses in the HippocampusNeuropharmacology, 1997
- Expression and Coupling to Polyphosphoinositide Hydrolysis of Group I Metabotropic Glutamate Receptors in Early Postnatal and Adult Rat BrainEuropean Journal of Neuroscience, 1997
- A novel class of antagonists for metabotropic glutamate receptors, 7-(Hydroxyimino)cyclopropa[b]chromen-1a-carboxylatesBioorganic & Medicinal Chemistry Letters, 1996
- Phenylglycine derivatives as antagonists of metabotropic glutamate receptorsTrends in Pharmacological Sciences, 1994
- Assessment of Neuronal Phosphoinositide Turnover and Its Disruption by LithiumNeuroprotocols, 1993